NRx Pharmaceuticals Provides Progress Update on Interactions with the FDA regarding Path to NDA Submission for NRX-101 ...Middle East

RADNOR, Pa., Jan. 19, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage central nervous system (CNS) biopharmaceutical company, today announced that it had a meeting and a written response from the Food and Drug...

Hence then, the article about nrx pharmaceuticals provides progress update on interactions with the fda regarding path to nda submission for nrx 101 was published today ( Thursday 19/01/2023 - 02:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NRx Pharmaceuticals Provides Progress Update on Interactions with the FDA regarding Path to NDA Submission for NRX-101 )

Also on site :

• The Dietitian-Approved Starbucks Matcha Order You Need To Try
• Dave Matthews Band Just Played a Secret Gig at Disney World’s Cinderella Castle—See the Video
• Fresca Turns Its Popular Citrus Soda Into 4 Boozy New Drinks